Skip to main content
Clinical Trials/NCT00601185
NCT00601185
Completed
Not Applicable

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo

Memorial Sloan Kettering Cancer Center4 sites in 1 country116 target enrollmentFebruary 14, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Basal Cell Carcinoma
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
116
Locations
4
Primary Endpoint
is to evaluate and quantify the technical feasibility of reflectance CSLM imaging of shave-biopsy sites on skin in vivo.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate a new instrument that shines light and takes digital pictures of skin. The goal is to develop a technique that may enable fast and accurate detection of skin disorders and cancers for future clinical diagnosis and surgical use.

Registry
clinicaltrials.gov
Start Date
February 14, 2006
End Date
February 23, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing shave-biopsy on an anatomical site that is readily accessible to the VivaScope 1500 (for example, chest, back, legs, arms, cheek, forehead).
  • The additional 110 patients for this amendment will be imaged with the newly developed Vivascope 3000 handheld confocal microscope.
  • Ability to sign informed consent.
  • Age ≥ 18 years.

Exclusion Criteria

  • Shave-biopsy located on a site that is not amenable to confocal imaging (for example, adjacent to the nose, ears or eyes, fingers, toes).
  • Inability to give informed consent.
  • Known hypersensitivity to adhesive rings.
  • Inability to tolerate imaging procedure (i. e., remain relatively still for multiple short durations of 3-4 minutes).

Outcomes

Primary Outcomes

is to evaluate and quantify the technical feasibility of reflectance CSLM imaging of shave-biopsy sites on skin in vivo.

Time Frame: conclusion of study

Secondary Outcomes

  • To assess the quality of the CSLM images of the biopsy sites to determine a point estimate of the proportion of images that will be of acceptable quality for formal analysis in the planned study of intraoperative margin detection.(conclusion of study)

Study Sites (4)

Loading locations...

Similar Trials